Glioblastoma Multiforme (GBM)
Oncology·MeSH: Glioblastoma
Prevalence
3.2 / 100K
Incidence
3.2 / 100K/yr
3 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Glioblastoma Multiforme (GBM)?
BioSniper tracks 3 drugs in development for Glioblastoma Multiforme (GBM) across 2 companies.
How many clinical trials target Glioblastoma Multiforme (GBM)?
There are 3 clinical trials targeting Glioblastoma Multiforme (GBM) tracked by BioSniper.
What is the prevalence of Glioblastoma Multiforme (GBM)?
The estimated prevalence of Glioblastoma Multiforme (GBM) is approximately 3.2 per 100,000 population.
Deep-dive into Glioblastoma Multiforme (GBM)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis